Article Text

Download PDFPDF
Why atropine drops should be used in Down syndrome
  1. C F Parsa,
  2. R Adyanthaya
  1. Wilmer Ophthalmological Institute, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
  1. C F Parsa, Wilmer Ophthalmological Institute, Johns Hopkins Hospital, Wilmer 233, 600 North Wolfe Street, Baltimore, MD 21287-9028, USA; cparsa{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

It is often stated that atropine drops should not be used, or are contraindicated, in children with Down syndrome.1 2 Some authors have stated that the mydriatic and cycloplegic effects are overly prolonged,3 whereas others have expressed apprehension regarding potential systemic toxicity.2 4 No evidence exists, however, to support either of these concerns.

It is plausible that previous investigators4 might have believed that the allegedly prolonged cycloplegic effect of atropine in Down syndrome patients could …

View Full Text


  • Competing interests: None declared.